Sienna Biopharmaceuticals, Inc. Made Big Gain
Tue 17 Dec 19 at 05:40 PM
Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ) soared at $0.14, representing a gain of 30.7%. The stock appeared on our News Catalysts scanner on Fri 13 Dec 19 at 12:16 PM in the 'RECOMMENDATION' category. From Mon 25 Nov 19, the stock recorded 35.71% Up Days and 40.00% Green Days
About Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ)
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.
Top 10 Gainers:
- Inpixon (INPX:NASDAQ), 100.78%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 34.33%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 31.04%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- 22nd Century Group, Inc. (XXII:NYSEMKT), 28.48%
- Renewable Energy Group, Inc. (REGI:NASDAQ), 26.92%
- Venus Concept Inc. (VERO:NASDAQ), 26.38%
- Precipio, Inc. (PRPO:NASDAQ), 25.97%
- TravelCenters of America Inc. (TA:NASDAQ), 24.5%
- Abraxas Petroleum Corporation (AXAS:NASDAQ), 23.7%